Polsky Center Announces Spring 2019 I-Corps Program Cohort
The Polsky Center has announced the latest cohort of the Polsky I-Corps program. Keep reading
The Polsky Center has announced the latest cohort of the Polsky I-Corps program. Keep reading
In 2014, the Bunning Food Allergy Professor Cathryn Nagler and her team discovered a potential treatment for food allergies. Keep reading
The intestinal microbiome seems to influence how well some cancer drugs work. But is the science ripe for clinical trials? Read the full article here >>
The University of Chicago announced a partnership with Benchmark Analytics to commercialize an early intervention system for police officers. Benchmark Analytics is a provider of analytics-based police force management and early intervention software solutions for law enforcement… Keep reading
The Polsky Center for Entrepreneurship and Innovation at the University of Chicago is pleased to announce the winners of the 21st annual Edward L. Kaplan, ’71, New Venture Challenge (NVC), a top-ranked accelerator program in the nation. Eleven companies competed in this… Keep reading
The idea that walking in nature is good for your head is not exactly groundbreaking science. But figuring out specifically how outdoor activity alleviates migraines? Now that is. Neurologist Richard Kraig thinks he has made that discovery and now hopes… Keep reading
The word microbiome has become a catch term only in the past decade, but it refers to something as old as humanity itself: the diverse and unimaginably vast population of microorganisms that share our bodies. These microbiota compose an ecosystem whose… Keep reading
Maintaining harmony within the gut is extraordinarily important to the human body, as this microbiome interacts with the immune, hormone and nervous system. Not only can a disruption in the gut can cause an upset stomach, scientists believe microbes play… Keep reading
A new University of Chicago startup is working to better predict the behavior of the trillions of microorganisms living inside the human body and harness them to treat disease. Gusto Global, co-founded by Prof. Jack Gilbert with the help of… Keep reading
Pharmaceutical giant AbbVie and University of Chicago have picked their initial set of projects to research cancer, a deadly disease given a renewed focus under the Obama administration. They include a new immunotherapy that could essentially weaponize a person’s immune… Keep reading
The University of Chicago Innovation Fund announced plans to invest up to $500,000 into two companies—Cephalgia Therapeutics and RWEDI water—that are working to combat migraines and increase water efficiency, respectively. These latest investments bring the Innovation Fund’s total investment amount… Keep reading